Volume 17, Issue 11, Pages (December 2016)

Slides:



Advertisements
Similar presentations
Volume 17, Issue 9, Pages (November 2016)
Advertisements

Volume 45, Issue 1, Pages (July 2016)
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Volume 136, Issue 4, Pages e3 (April 2009)
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
Volume 17, Issue 1, Pages (September 2016)
Volume 13, Issue 6, Pages (November 2015)
Volume 18, Issue 1, Pages (January 2017)
Volume 42, Issue 5, Pages (May 2015)
Volume 12, Issue 12, Pages (September 2015)
Volume 30, Issue 1, Pages (January 2009)
Volume 25, Issue 5, Pages (November 2006)
Volume 140, Issue 7, Pages (June 2011)
Volume 29, Issue 6, Pages (December 2008)
Volume 28, Issue 4, Pages (April 2008)
Volume 17, Issue 12, Pages (December 2016)
Volume 40, Issue 6, Pages (June 2014)
Volume 143, Issue 1, Pages (July 2012)
Volume 36, Issue 5, Pages (May 2012)
PIAS1 Promotes Lymphomagenesis through MYC Upregulation
Volume 138, Issue 2, Pages (February 2010)
Volume 42, Issue 4, Pages (April 2015)
Volume 41, Issue 1, Pages (July 2014)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Volume 12, Issue 4, Pages (October 2012)
Volume 34, Issue 4, Pages (April 2011)
Volume 16, Issue 4, Pages (July 2016)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 36, Issue 3, Pages (March 2012)
Volume 24, Issue 2, Pages (February 2006)
Volume 26, Issue 1, Pages (January 2018)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 33, Issue 5, Pages (November 2010)
Volume 17, Issue 8, Pages (November 2016)
Volume 48, Issue 4, Pages e6 (April 2018)
Volume 27, Issue 5, Pages (November 2007)
Volume 41, Issue 4, Pages (October 2014)
Volume 43, Issue 1, Pages (July 2015)
Volume 17, Issue 2, Pages (February 2009)
Volume 23, Issue 3, Pages (April 2018)
Nathalie Schmitt, Yang Liu, Salah-Eddine Bentebibel, Hideki Ueno 
Volume 44, Issue 1, Pages (January 2016)
Volume 46, Issue 4, Pages (April 2017)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 19, Issue 11, Pages (June 2017)
Volume 126, Issue 6, Pages (September 2006)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 32, Issue 5, Pages (May 2010)
Volume 17, Issue 9, Pages (November 2016)
Volume 41, Issue 2, Pages (August 2014)
Volume 17, Issue 5, Pages (October 2016)
Volume 28, Issue 1, Pages (January 2008)
Volume 13, Issue 6, Pages (June 2013)
Volume 35, Issue 4, Pages (October 2011)
Volume 22, Issue 8, Pages (February 2018)
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
Yunqi Wang, Maureen A. Su, Yisong Y. Wan  Immunity 
Volume 13, Issue 6, Pages (November 2015)
Volume 31, Issue 2, Pages (August 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 8, Issue 6, Pages (June 2017)
Volume 39, Issue 5, Pages (November 2013)
Volume 44, Issue 6, Pages (June 2016)
Volume 33, Issue 1, Pages (July 2010)
Volume 27, Issue 10, Pages e7 (June 2019)
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 38, Issue 2, Pages (February 2013)
Volume 2, Issue 6, Pages (December 2012)
Presentation transcript:

Volume 17, Issue 11, Pages 2827-2836 (December 2016) Id3 Maintains Foxp3 Expression in Regulatory T Cells by Controlling a Transcriptional Network of E47, Spi-B, and SOCS3  Katharina S. Rauch, Miriam Hils, Ekaterina Lupar, Susana Minguet, Mikael Sigvardsson, Martin E. Rottenberg, Ana Izcue, Christian Schachtrup, Kristina Schachtrup  Cell Reports  Volume 17, Issue 11, Pages 2827-2836 (December 2016) DOI: 10.1016/j.celrep.2016.11.045 Copyright © 2016 The Authors Terms and Conditions

Cell Reports 2016 17, 2827-2836DOI: (10.1016/j.celrep.2016.11.045) Copyright © 2016 The Authors Terms and Conditions

Figure 1 Id3 Maintains Foxp3 Expression in Treg Cells (A) Percentage of Foxp3+ cells among transferred cells immediately before and 7 days after transfer (in spleen) of FACS-sorted Treg cells (CD4+TCRβ+CD8−CD45RBloCD25+) isolated from WT and Id3−/− mice (Thy1.2+) into WT mice (Thy1.1+) (n = 3). (B) Percentage of Foxp3+ cells immediately before and after 3 days of in vitro anti-CD3/CD28 stimulation of FACS-sorted Treg cells (CD4+TCRβ+CD8−CD45RBloCD25+) isolated from WT and Id3−/− mice (n = 3–5). (C) Percentage of Foxp3+ cells in cells that had not divided (0 div.) or divided 2–4 times (2–4 div.) after 3 days of in vitro anti-CD3/CD28 stimulation of FACS-sorted Treg cells (CD4+TCRβ+CD8−CD45RBloCD25+) isolated from WT and Id3−/− mice based on their CFSE (carboxyfluorescein succinimidyl ester) level, as indicated (n = 3–5, mean ± SEM; same cells as in B). (D) Percentage of Foxp3+ cells in spleen and MLNs among transferred Treg cells (Thy1.2+) immediately before and at the endpoint of the experiment (either days 33–53 post-transfer or 2 days after mice had lost >20% of their original weight) after transfer of FACS-sorted naive-like Treg cells (CD4+TCRβ+CD8−CD62LhiCD45RBloCD25+) isolated from WT and Id3−/− mice (Thy1.2+) together with CD4+CD25−CD45RBhi effector T cells (Thy1.1+) into Rag−/− mice (n = 5 experiments; each point corresponds to an individual mouse). (E) Colitis scores of Rag−/− mice that received only CD4+CD25−CD45RBhi effector T cells (black squares) or that were co-transferred with WT (white circles) or Id3−/− Treg cells (black circles) (n = 5 experiments; each point corresponds to an individual mouse). Representative micrographs show H&E-stained sections of mid-colon. Scale bars, 500 μm (top row) and 100 μm (bottom row). ∗p < 0.05; ∗∗p < 0.01; ns, not significant, Student’s t test. See also Figure S1. Cell Reports 2016 17, 2827-2836DOI: (10.1016/j.celrep.2016.11.045) Copyright © 2016 The Authors Terms and Conditions

Figure 2 E47 Downregulates Foxp3 Transcription (A) Percentage of Foxp3+ cells among Thy1.1+ cells of in vitro anti-CD3/CD28-stimulated Treg cells transduced with retroviral vectors encoding IRES-Thy1.1 (pMIT) or E47-IRES-Thy1.1 (pMIT-E47) at 24, 48, and 72 hr post-transduction (n = 5, mean ± SEM). (B) Percentage of Foxp3+ cells in spleen and MLNs among transferred (Thy1.2+) and transduced (Thy1.1+) Treg cells at the endpoint of the experiment (either 40 days post-transfer or 2 days after mice had lost >20% of their original weight) after transfer of retroviral-transduced FACS-sorted Treg cells (CD4+RFP+Thy1.1+) isolated from Foxp3-RPF mice and transduced with retroviral vectors encoding IRES-Thy1.1 (pMIT) or E47-IRES-Thy1.1 (pMIT-E47) together with CD4+CD25−CD45RBhi effector T cells (Thy1.2−Thy1.1+) into Rag−/− mice (n = 2 experiments; each point corresponds to an individual mouse). (C) qRT-PCR analysis of Foxp3 mRNA transcripts in Thy1.1+ cells from WT CD4+CD25− cells transduced with pMIT or pMIT-E47 and stimulated with anti-CD3/CD28 and TGF-β at 24 hr post-transduction (n = 6, mean ± SEM). (D–F) Luciferase reporter assay in RLM-11-1 cells transiently transfected with (D) the indicated WT Foxp3 reporter construct together with increasing amounts of E47 (black bars) or control (white bar) expression vectors, (E) the WT or CNS2-mutated Foxp3 reporter construct together with E47 (black bars) or control (white bars) expression vectors and (F) the indicated WT Foxp3 reporter construct together with WT or mutant E47 (black bars) or control (white bar) expression vectors after 18 hr of P/I stimulation. Normalized luciferase activities are shown as fold changes compared to the mean luciferase activity in the absence of the E47 expression vector (n ≥ 3, mean ± SEM). (G) Percentage of Foxp3+ cells among Thy1.1+ cells of in vitro anti-CD3/CD28-stimulated Treg cells transduced with retroviral vectors encoding IRES-Thy1.1 (pMIT), E47-IRES-Thy1.1 (pMIT-E47), or E47R558K-IRES-Thy1.1 (pMIT-E47R558K) at 72 hr post-transduction (n = 3, mean ± SEM). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns: not significant, Student’s t test. See also Figures S2 and S3. Cell Reports 2016 17, 2827-2836DOI: (10.1016/j.celrep.2016.11.045) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Spi-B Represses Foxp3 Expression in Treg Cells (A) Heatmap of genes that are differentially expressed (>1.5-fold) in TGF-β-induced Treg cells, transduced with pMIT-E47-ER compared to pMIT-bHLH-ER-transduced cells, and treated with OHT for 6 hr. (B) Percentage of Foxp3+ cells among Thy1.1+ cells of WT CD4+CD25− cells transduced with pMIT or pMIT-SpiB and stimulated with anti-CD3/CD28 and TGF-β at 24 and 72 hr post-transduction (n = 6, mean ± SEM). Displayed FACS blots represent cells at 24 hr post-transduction. (C) qRT-PCR analysis of Foxp3 mRNA transcripts in Thy1.1+ cells from WT CD4+CD25− cells transduced with pMIT-SpiB-ER and stimulated with anti-CD3/CD28 and TGF-β in the absence or presence of OHT for 24 hr (n = 3, mean ± SEM). (D) Percentage of Foxp3+ cells among Thy1.1+ cells of in vitro anti-CD3/CD28-stimulated Treg cells transduced with pMIT or pMIT-SpiB at 72 hr post-transduction (n = 9, mean ± SEM). (E) Percentage of Foxp3+ cells in spleen and MLNs among transferred (Thy1.2+) and transduced (Thy1.1+) Treg cells at the endpoint of the experiment (either 40 days post-transfer or 2 days after mice had lost >20% of their original weight) after transfer of retroviral-transduced FACS-sorted Treg cells (CD4+RFP+Thy1.1+) isolated from Foxp3-RPF mice and transduced with retroviral vectors encoding IRES-Thy1.1 (pMIT) or SpiB-IRES-Thy1.1 (pMIT-SpiB) together with CD4+CD25−CD45RBhi effector T cells (Thy1.2−Thy1.1+) into Rag−/− mice (n = 2 experiments; each point corresponds to an individual mouse). (F) qRT-PCR analysis of Spib mRNA transcripts in WT and Id3−/− Treg cells stimulated with anti-CD3/CD28 for 72 hr (n = 3, mean ± SEM). (G) qRT-PCR analysis of Spib mRNA transcripts in Thy1.1+ cells isolated from WT Treg cells (CD4+CD25+) transduced with pMIT or pMIT-E47 and stimulated with anti-CD3/CD28 at 72 hr post-transduction (n = 3, mean ± SEM). ∗p ≤ 0.05; ∗∗p ≤ 0.01; ∗∗∗p < 0.001, Student’s t test. See also Figure S4. Cell Reports 2016 17, 2827-2836DOI: (10.1016/j.celrep.2016.11.045) Copyright © 2016 The Authors Terms and Conditions

Figure 4 E47 Represses Foxp3 Expression in Treg Cells via SOCS3 (A–C) qRT-PCR analysis of (A) Foxp3, (B) Spib or E47 and (C) Socs3 mRNA transcripts in Thy1.1+ cells from WT CD4+CD25− cells transduced with pMIT-E47-ER or pMIT-SpiB-ER and stimulated with anti-CD3/CD28 and TGF-β for 24 hr in the absence or presence of OHT and CHX as indicated (n : 2, mean ± SEM). (D) qRT-PCR analysis of Socs3 mRNA transcripts in WT and Id3−/− Treg cells stimulated with anti-CD3/CD28 for 72 hr (n = 4, mean ± SEM). (E) Percentage of Foxp3+ cells among Thy1.1+ cells of WT CD4+CD25− cells transduced with pMIT or pMIT-SOCS3 and stimulated with anti-CD3/CD28 and TGF-β at 24 and 72 hr post-transduction (n = 7, mean ± SEM). Displayed FACS blots represent cells at 24 hr post-transduction. (F) Percentage of Foxp3+ cells among Thy1.1+ cells of in vitro anti-CD3/CD28-stimulated Treg cells transduced with pMIT or pMIT-SOCS3 at 72 hr post-transduction (n = 6, mean ± SEM). (G) Percentage of Foxp3+ cells among Thy1.1+ cells of control (Socs3fl/fl) or SOCS3-deficient (Socs3fl/fl lck cre) in vitro anti-CD3/CD28-stimulated Treg cells transduced with pMIT or pMIT-E47 at 24 and 72 hr post-transduction (n = 2, mean ± SEM). (H) Schematic model for the E47-mediated Foxp3 repression. ∗p ≤ 0.05; ∗∗p ≤ 0.01; ns, not significant, Student’s t test. Cell Reports 2016 17, 2827-2836DOI: (10.1016/j.celrep.2016.11.045) Copyright © 2016 The Authors Terms and Conditions